blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1597271

EP1597271 - PEPTIDES DIRECTED AGAINST ANTIBODIES, WHICH CAUSE COLD-INTOLERANCE, AND THE USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.01.2014
Database last updated on 22.05.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
Robert-Rössle-Strasse 10
13125 Berlin / DE
[2008/18]
Former [2005/47]For all designated states
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
Robert-Rössle-Strasse 10
13125 Berlin / DE
For all designated states
Friedrich-Alexander-Universität Erlangen-Nürnberg
Schlossplatz 4
91054 Erlangen / DE
Inventor(s)01 / WALLUKAT, Gerd
Wolkensteinstr. 4
13129 Berlin / DE
02 / HARRER, Thomas
Burgbergstr. 15a
91054 Erlangen / DE
 [2005/47]
Representative(s)Spieker, Oliver, et al
HERTIN Anwaltssozietät
Kurfürstendamm 54/55
10707 Berlin / DE
[N/P]
Former [2005/47]Spieker, Oliver, et al
HERTIN Anwaltssozietät, Kurfürstendamm 54/55
10707 Berlin / DE
Application number, filing date04706129.629.01.2004
[2005/47]
WO2004DE00169
Priority number, dateDE200310516531.01.2003         Original published format: DE 10305165
DE200311110606.03.2003         Original published format: DE 10311106
[2005/47]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2004067549
Date:12.08.2004
Language:DE
[2004/33]
Type: A2 Application without search report 
No.:EP1597271
Date:23.11.2005
Language:DE
The application published by WIPO in one of the EPO official languages on 12.08.2004 takes the place of the publication of the European patent application.
[2005/47]
Type: B1 Patent specification 
No.:EP1597271
Date:06.03.2013
Language:DE
[2013/10]
Search report(s)International search report - published on:EP07.10.2004
ClassificationIPC:C07K7/06, C12N15/11, C12N15/12, C07K16/18, A61K38/03
[2005/47]
CPC:
B01J20/3242 (EP,US); B01J20/286 (EP,US); C07K14/4713 (EP,US);
C07K14/705 (EP,US); A61K38/00 (EP,US); B01D15/3809 (EP,US);
C12N2799/021 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/47]
TitleGerman:PEPTIDE GEGEN KÄLTEUNVERTRÄGLICHKEIT HERVORRUFENDE AUTOANTIKÖRPER UND IHRE VERWENDUNG[2005/47]
English:PEPTIDES DIRECTED AGAINST ANTIBODIES, WHICH CAUSE COLD-INTOLERANCE, AND THE USE THEREOF[2005/47]
French:PEPTIDES DIRIGES CONTRE DES AUTOANTICORPS RESULTANT DE L'INTOLERANCE AU FROID, ET LEUR UTILISATION[2005/47]
Entry into regional phase30.08.2005National basic fee paid 
30.08.2005Designation fee(s) paid 
30.08.2005Examination fee paid 
Examination procedure31.08.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.08.2005Examination requested  [2005/47]
15.11.2005Despatch of a communication from the examining division (Time limit: M04)
24.03.2006Reply to a communication from the examining division
10.07.2007Despatch of a communication from the examining division (Time limit: M06)
21.01.2008Reply to a communication from the examining division
16.04.2009Despatch of a communication from the examining division (Time limit: M06)
26.10.2009Reply to a communication from the examining division
15.02.2012Date of oral proceedings
27.04.2012Minutes of oral proceedings despatched
29.08.2012Communication of intention to grant the patent
18.12.2012Fee for grant paid
18.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.11.2005
Opposition(s)09.12.2013No opposition filed within time limit [2014/07]
Fees paidRenewal fee
30.08.2005Renewal fee patent year 03
29.11.2006Renewal fee patent year 04
14.12.2007Renewal fee patent year 05
25.11.2008Renewal fee patent year 06
23.11.2009Renewal fee patent year 07
28.12.2010Renewal fee patent year 08
14.01.2012Renewal fee patent year 09
21.01.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.01.2004
CY06.03.2013
CZ06.03.2013
DK06.03.2013
EE06.03.2013
FI06.03.2013
IT06.03.2013
MC06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
TR06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
[2016/33]
Former [2016/32]HU29.01.2004
CY06.03.2013
CZ06.03.2013
DK06.03.2013
EE06.03.2013
FI06.03.2013
IT06.03.2013
MC06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2014/38]CY06.03.2013
CZ06.03.2013
DK06.03.2013
EE06.03.2013
FI06.03.2013
IT06.03.2013
MC06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2014/11]CY06.03.2013
CZ06.03.2013
DK06.03.2013
EE06.03.2013
FI06.03.2013
IT06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2014/09]CY06.03.2013
CZ06.03.2013
DK06.03.2013
EE06.03.2013
FI06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2013/52]CY06.03.2013
CZ06.03.2013
EE06.03.2013
FI06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2013/49]CZ06.03.2013
EE06.03.2013
FI06.03.2013
NL06.03.2013
RO06.03.2013
SE06.03.2013
SI06.03.2013
SK06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2013/48]EE06.03.2013
FI06.03.2013
NL06.03.2013
SE06.03.2013
SI06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2013/47]FI06.03.2013
SE06.03.2013
SI06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
PT08.07.2013
Former [2013/37]FI06.03.2013
SE06.03.2013
SI06.03.2013
BG06.06.2013
GR07.06.2013
ES17.06.2013
Former [2013/36]SE06.03.2013
BG06.06.2013
ES17.06.2013
Former [2013/34]SE06.03.2013
BG06.06.2013
Cited inInternational search[X]JP2002010784  (TEIJIN LTD) [X] 1-20 * sequences 102-108 *;
 [E]WO2004051280  (MAX DELBRUECK CENTRUM [DE], et al) [E] 7-32 * claims 12-31 *;
 [X]  - "Human thrombin receptor mRNA; complete cds", EMBL, (19910406), Database accession no. M62424, XP002290141 [X] 1-14,17,18 * PAR-1; column A *
 [X]  - "Proteinase activated receptor 1 precursor (PAR-1) (Thrombin receptor) (Coagulation factor II receptor)", UNIPROT, (19920501), Database accession no. P25116, XP002290142 [X] 7-14,17,18 * column A *
 [X]  - "Proteinase activated receptor 2 precursor (PAR-2) (Thrombin receptor-like 1)(Coagulation factor II receptor-like 1)", UNIPROT, (19961001), Database accession no. P55085, XP002290143 [X] 7-14,17,18 * column A *
 [X]  - "Proteinase activated receptor 3 precursor (PAR-3) (Thrombin receptor-like 2) (Coagulation factor II receptor-like 2)", UNIPROT, (19980715), Database accession no. O00254, XP002290144 [X] 7-14,17,18 * column A *
 [A]  - MACFARLANE S R ET AL, "Proteinase-activated receptors", PHARMACOLOGICAL REVIEWS, WILLIAMS AND WILKINS INC., BALTIMORE, MD,, US, (200106), vol. 53, no. 2, ISSN 0031-6997, pages 245 - 282, XP002234540 [A] 1-34 * the whole document *
Examination   - TAKAMI, "Genome sequence of Oceanobacillus iheyensis isolated from the Iheya Ridge and its unexpected adaptive capabilities to extreme environments", NUCLEIC ACIDS RESEARCH, (2002), vol. 30, no. 18, doi:doi:10.1093/nar/gkf526, XP001183039

DOI:   http://dx.doi.org/10.1093/nar/gkf526
    - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 475319-02-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.